Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments
Purpose: RANKL expression in the tumor microenvironment has been identified as a biomarker of immune suppression, negating the effect of some cancer immunotherapies. Previously we had developed a radiotracer based on the FDA-approved RANKL-specific antibody denosumab, [<sup>89</sup>Zr]Zr...
Saved in:
Main Authors: | Jonatan Dewulf (Author), Ivanna Hrynchak (Author), Sarah Geudens (Author), Isabel Pintelon (Author), Christel Vangestel (Author), José Sereno (Author), Peter A. van Dam (Author), Antero J. Abrunhosa (Author), Filipe Elvas (Author), Tim Van den Wyngaert (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
by: Jonatan Dewulf, et al.
Published: (2023) -
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging
by: Laure Badier, et al.
Published: (2024) -
Radiolabeling of Nanoparticles and Polymers for PET Imaging
by: Katharina Stockhofe, et al.
Published: (2014) -
Strategies and Applications of Antigen-Binding Fragment (Fab) Production in Escherichia coli
by: Hui Chen, et al.
Published: (2021) -
Radiolabelled Molecules for Brain Imaging with PET and SPECT
Published: (2020)